The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients.

Kosuke MimaNobutomo MiyanariKeisuke KosumiTakuya TajiriKosuke KanemitsuToru TakematsuMitsuhiro InoueTakao MizumotoTatsuo KubotaHideo Baba

Published in: International journal of clinical oncology (2021)

Selected frail patients with CRC may experience a similar survival benefit from adjuvant chemotherapy as non-frail patients. Clinical trials are needed to establish adjuvant chemotherapy for CRC in frail patients.

Keyphrases

end stage renal disease
ejection fraction
clinical trial
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
randomized controlled trial
community dwelling
phase ii